CARsgen Therapeutics Holdings Limited (HKG:2171)

HKG:2171 Revenue

CARsgen Therapeutics Holdings had revenue of 74.70M CNY in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 136.62M, up 62.55% year-over-year. In the year 2025, CARsgen Therapeutics Holdings had annual revenue of 125.66M with 218.74% growth.

• Revenue (ttm): 136.62M CNY
• Revenue Growth: +62.55%
• P/S Ratio: 53.54
• Revenue / Employee: 384.85K CNY
• Employees: 355
• Market Cap: 8.44B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	125.66M	86.24M	218.74%
Dec 31, 2024	39.43M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	25.81M	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error